About Dowpharma - A Business Unit of The Dow Chemical Company

Dowpharma^SM contract manufacturing services, a business unit of The Dow Chemical Company, serves the pharmaceutical and biopharmaceutical industries with innovative technology, products, and services for clients in drug discovery, development, manufacturing and delivery. We combine the resources and capabilities of several offerings to create a single, market-focused organization with broad service and support capabilities for large and emerging pharmaceutical companies.

We start by taking the time to understand your needs, goals and vision and your expectations of how we’ll work together to move your project forward. An intense customer focus enables us to deliver effective, tailored solutions to your specific needs.

Technology Platforms:
Biopharmaceuticals, Peptides & PEGylation
Small Molecules

Expertise
Dowpharma draws upon more than 30 years of excellent cGMP regulatory compliance in the organic synthesis of APIs and pharmaceutical intermediates with the ability to provide client support in filing and validation strategies. Dowpharma operates research, process development, and manufacturing facilities in North America and Europe.

We have also formed a number of strategic alliances with leaders in carbohydrate-based pharmaceuticals and nutraceuticals, chiral compounds, unique separation processes and formulation.

The result is one of the broadest and deepest global outsourcing capabilities in the industry with more than three decades’ experience in manufacturing and scale up services from the bench through commercial launch, and other innovative technologies, products, and services for drug development and delivery.


Small Molecules Capabilities and Services Biocatalysis Biocatalysis Capability Collaborators Enzyme Classes Chemocatalysis Asymmetric Hydrogenation Hydroformylation Trost Allylic Alkylation Complex Synthesis Products Offered Process Development Customer Needs Development Timeline Emerging Pharma Catalyst/Ligand Availability Unnatural Fmoc Amino Acids Unnatural Boc Amino Acids 2-Alkyl Succinates Amines Alcohols Functionalized Cyclopentanes Scaffolds Facilities Literature and Resources Asymmetric Hydrogenation Dowpharma Scientific Publications Hydroformylation Trost Allylic Alkylation Complex Synthesis Biocatalysis Process Development General Publications News Source: Aquapharm Bio-Discovery Ltd Enters a Collaboration Deal with Dowpharma<sup>SM</sup> Contract Manufacturing Services. Dowpharma Relaunches Web Site, Will Make Donation to UNICEF Dow Expands Presence in Pharmaceutical Market, Uniting Existing Offers Under Dowpharma Portfolio Dowpharma Announces New Capabilities in Asymmetric Hydroformylation for Pharmaceutical Applications License of JST Catalyst Technology Expands Dowpharma’s Chiral Commercial Production Capabilities Dowpharma Signs Agreement with Japanese Distributor to Market Pharmaceutical Services in Japan Events Calendar REACH Contact Us Biopharmaceuticals & Peptides Capabilities and Services Molecular Biology Expression Technologies Pfēnex Expression Technology Fermentation Process Development Purification Process Development Analytical Development Pilot Manufacturing cGMP Manufacturing Project Lifecycle Timeline PEGylation Why PEGs? Chemistry Analytical Why Dowpharma? Dowpharma PEGs Ordering PEGs Order Summary Checkout Thank You Events Calendar Facilities Literature and Resources News Dow Announces Price Increases of its Epoxy Novolac Resins In Asia Pacific, Europe, Middle East, Africa, India and Pakistan DowpharmaSM Announces Multi-Product License Agreement with Merck Dowpharma<sup>SM</sup> Signs Fourth Collaboration Agreement In First Quarter of 2006 for <i>Pf</i>ēnex Expression Technology™ DOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin VGX Pharmaceuticals and Dowpharma<sup>SM</sup> Sign Research and Development Agreement for VGX’s Lead Cancer Compound Viventia Biotech and Dowpharma<sup>SM</sup> Announce a Multi-Product Commercial License Agreement using <i>Pf</i>ēnex Expression Technology™ from Dowpharma DOR BioPharma and Dowpharma<sup>SM</sup> Complete Feasibility Study for Production of BT-VACC™, DOR’s Recombinant Botulinum Vaccine DOR BioPharma and Dowpharma Enter into a Joint Development Agreement for BT-VACC, DOR’s Oral Botulinum Toxin Vaccine Dowpharma<sup>SM</sup> Announces Commercial License Agreement for <i>Pf</i><script>document.write(unescape('%u0113'));</script>nex Expression Technology™ with Iomai Corporation <i>Smithsonian National Museum of American History</i> - Dow Donates DNA Fermenter to National Museum of American History Cambrex Named First Biopharmaceutical Manufacturing Partner for <i>Pf</i>ēnex Expression Technology™ from Dowpharma<sup>SM</sup> Dowpharma Relaunches Web Site, Will Make Donation to UNICEF Dowpharma<sup>SM</sup> Announces Agreement with Pfizer Inc using <i>Pf</i><script>document.write(unescape('%u0113'));</script>nex Expression Technology<sup>TM</sup> and Dow Solvent Extraction Tech. Dowpharma Sharpens Focus on New Expression Systems; Smithfield Facility Will be Closed Dowpharma Consolidates Biopharmaceutical Process Development to San Diego Dowpharma Announces Biologics Peptide Manufacture Dow Expands Presence in Pharmaceutical Market, Uniting Existing Offers Under Dowpharma Portfolio Dowpharma Introduces Next Generation Microbial Expression System for Production of Biotherapeutics Events Calendar PEGylation REACH Contact Us About Us REACH Contact Us	About Dowpharma - A Business Unit of The Dow Chemical Company Dowpharma^SM contract manufacturing services, a business unit of The Dow Chemical Company, serves the pharmaceutical and biopharmaceutical industries with innovative technology, products, and services for clients in drug discovery, development, manufacturing and delivery. We combine the resources and capabilities of several offerings to create a single, market-focused organization with broad service and support capabilities for large and emerging pharmaceutical companies. We start by taking the time to understand your needs, goals and vision and your expectations of how we’ll work together to move your project forward. An intense customer focus enables us to deliver effective, tailored solutions to your specific needs. Technology Platforms: Biopharmaceuticals, Peptides & PEGylation Small Molecules Expertise Dowpharma draws upon more than 30 years of excellent cGMP regulatory compliance in the organic synthesis of APIs and pharmaceutical intermediates with the ability to provide client support in filing and validation strategies. Dowpharma operates research, process development, and manufacturing facilities in North America and Europe. We have also formed a number of strategic alliances with leaders in carbohydrate-based pharmaceuticals and nutraceuticals, chiral compounds, unique separation processes and formulation. The result is one of the broadest and deepest global outsourcing capabilities in the industry with more than three decades’ experience in manufacturing and scale up services from the bench through commercial launch, and other innovative technologies, products, and services for drug development and delivery.
	Dowpharma Home Dow Home Privacy Statement Internet Disclaimer Accessibility Statement Site Map Copyright © The Dow Chemical Company (1995-2008). All Rights Reserved.